---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-062300"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2022-10-06T23:59:59+00:00"
generated_at: "2026-06-23T05:14:54.094487+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Emmaus Life Sciences appoints Ian Zwicker and Dr. Seah Lim to Board; Lim loans $1.2M

## Summary
- Ian Zwicker appointed to Board and as Chair of Audit Committee; will receive $25,000 for audit committee service.
- Dr. Seah Lim appointed to fill Board vacancy; brings expertise in hematology, oncology, and sickle cell disease.
- Dr. Lim loaned Emmaus $1.2M at 6% interest, due in 3 years, with one restricted share per $5 principal.
- Loan proceeds used to augment working capital and for general corporate purposes.

## SEC filing metadata
- accession: 0001213900-22-062300
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2022-10-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390022062300/0001213900-22-062300-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390022062300/ea166525-8k_emmauslife.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-062300
- JSON: https://secwatch.observer/filing/0001213900-22-062300.json
- Plain text: https://secwatch.observer/filing/0001213900-22-062300.txt

## Key facts
- Executive change
  Ian Zwicker was appointed as Director and Chair of Audit Committee at Emmaus Life Sciences, Inc..
  - Action: appointed
  - Role: Director and Chair of Audit Committee
  source text: the Board appointed Ian Zwicker as a director of the company and as the Chair and sole member of the Audit Committee
  evidence_url: https://www.sec.gov/Archives/edgar/data/822370/000121390022062300/0001213900-22-062300-index.htm
- Executive change
  Seah H. Lim was appointed as Director at Emmaus Life Sciences, Inc..
  - Action: appointed
  - Role: Director
  source text: The Board also appointed Seah H. Lim, M.D., Ph.D. as a director to fill a vacancy on the five-person Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/822370/000121390022062300/0001213900-22-062300-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.